flutamide has been researched along with Anemia in 6 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"One hundred and thirty-six patients with adenocarcinoma of prostate were treated with combined androgen block (orchiectomy and flutamide 250 mg, tid)." | 3.72 | Anemia in patients on combined androgen block therapy for prostate cancer. ( Cheng, SG; Hua, LX; Li, J; Qian, LX; Sui, YG; Wang, XR; Wu, HF; Zhang, W, 2004) |
"47 patients with clinical localised prostate cancer were given LH-RH analogs plus flutamide for complete androgenic blockade (CAB) for at least 3 months prior to radical prostatectomy." | 1.31 | [Anemia and neoadjuvant hormone therapy in radical surgery of localized cancer of the prostate]. ( Arango Toro, O; Bielsa Gali, O; Gelabert Mas, A; Griño Garreta, J; Lorente Garín, JA, 2001) |
"Patients with prostate cancer were evaluated prospectively by physical examination and laboratory tests at baseline and at routine intervals while receiving CHB." | 1.30 | Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. ( Johnson, H; McDermed, JE; Scholz, MC; Strum, SB; Tisman, G, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qian, LX | 1 |
Hua, LX | 1 |
Wu, HF | 1 |
Sui, YG | 1 |
Cheng, SG | 1 |
Zhang, W | 1 |
Li, J | 1 |
Wang, XR | 1 |
Voegeli, TA | 1 |
Kurtz, A | 1 |
Grimm, MO | 1 |
Effert, P | 1 |
Eckardt, KU | 1 |
Asbell, SO | 1 |
Leon, SA | 1 |
Tester, WJ | 1 |
Brereton, HD | 1 |
Ago, CT | 1 |
Rotman, M | 1 |
Strum, SB | 1 |
McDermed, JE | 1 |
Scholz, MC | 1 |
Johnson, H | 1 |
Tisman, G | 1 |
Ornstein, DK | 1 |
Beiser, JA | 1 |
Andriole, GL | 1 |
Arango Toro, O | 1 |
Lorente Garín, JA | 1 |
Bielsa Gali, O | 1 |
Griño Garreta, J | 1 |
Gelabert Mas, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Multi-center Study to Assess the Effect of Darbepoetin Alfa (Aranesp®) for the Treatment of Anemia in Patients With Advanced Hormone Independent Prostate Cancer and Anaemia[NCT00381836] | Phase 2/Phase 3 | 140 participants (Anticipated) | Interventional | 2006-10-31 | Terminated (stopped due to Terminated by sponsor due to general risk that aranesp caused tumor progression) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for flutamide and Anemia
Article | Year |
---|---|
Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy.
Topics: Aged; Androgen Antagonists; Anemia; Antineoplastic Agents, Hormonal; Black People; Combined Modality | 1996 |
5 other studies available for flutamide and Anemia
Article | Year |
---|---|
Anemia in patients on combined androgen block therapy for prostate cancer.
Topics: Adenocarcinoma; Adult; Androgen Antagonists; Anemia; Antineoplastic Agents, Hormonal; Combined Modal | 2004 |
Anemia under androgen deprivation: influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system.
Topics: Androgen Antagonists; Androgens; Anemia; Animals; Cyproterone Acetate; Erythropoietin; Flutamide; He | 2005 |
Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade.
Topics: Age Factors; Aged; Anemia; Anilides; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Fl | 1997 |
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; | 1999 |
[Anemia and neoadjuvant hormone therapy in radical surgery of localized cancer of the prostate].
Topics: Androgen Antagonists; Anemia; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Flutamide; He | 2001 |